Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)

Summary

The aim of the study is to assess the use of the apomorphine pump in earlier stages of Parkinson' Disease (PD), when motor complications have just developed and before patients are significantly affected in their social and occupational functioning. The investigators hypothesize that apomorphine pump is superior in terms of positive impact on quality of life (QoL) to oral medical therapy alone at a relatively early stage of PD, before the appearance of severe disabling motor complications thus favoring the maintain of patients' social and occupational status with a significant positive economic impact of the health system.

Timeline

Start

2017-03-03

Primary completion

2024-01-12

Completion

2025-01-10

Drugs

Indications